Expression of IFNγrel 1 mRNA significantly increased during acute allograft rejection.
Recombinant IFNγrel 1 administration increased T cells and sIgM+ cells in scale allografts and enhanced allograft rejection.
Expression of IFNγ1, IFNγ2 and effector molecule mRNA was up-regulated by rgIFNγrel 1 administration.